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Edited by Judit OvadiAbstract Amphibian skin is a rich resource of antimicrobial
peptides, like maximins and maximin Hs from frog Bombina
maxima. Novel cDNA clones encoding a precursor protein,
which comprises a novel maximin peptide (maximin 9) and re-
ported maximin H3, were isolated from two constructed skin
cDNA libraries of B. maxima. The predicted primary structure
of maximin 9 is GIGRKFLGGVKTTFRCGVKDFASKHLY-
NH2. A surprising substitution is at position 16, with a free cys-
teine in maximin 9 rather than usual conserved glycine in other
reported maximins. Maximin 9, the homodimer form and its
Cys16 to Gly16 mutant were synthesized and their antimicrobial
activities were evaluated. Unlike previously reported maximin
3, the tested bacterial and fungal strains were resistant to maxi-
min 9, its homodimer and the Cys16 to Gly16 mutant (with
MICs > 100 lM). On the other hand, interestingly, while eight
clinical Mollicutes strains were generally resistant to maximin
9 homodimer and its Cys16 to Gly16 mutant, most of them are
sensitive to maximin 9 at a peptide concentration of 30 lM,
especially in the presence of dithiothreitol. These results indicate
that the presence of a reactive Cys residue in maximin 9 is
important for its antimycoplasma activity. The diversity of anti-
microbial peptide cDNA structures encountered in B. maxima
skin cDNA libraries and the antimicrobial speciﬁcity diﬀerences
of the peptides may reﬂect well the species adaptation to the un-
ique microbial environments.
 2005 Federation of EuropeanBiochemical Societies. Published
by Elsevier B.V. All rights reserved.
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In recent years, a large number of antimicrobial peptides
have been characterized from animals and plants. These mole-
cules, which are either constitutive or inducible, are recognized
as important components of innate defense system [1–3].
Amphibians, being the ﬁrst group of organisms forming a con-
necting link between land and water, are forced to adopt and
survive in a variety of conditions laden with pathogenic
microbes. Therefor, they are endowed with an excellent chem-q The nucleotide sequence data reported in this paper is available
from GenBank database with accession number of AY652770.
*Corresponding author. Fax: +86 871 5191823.
E-mail address: zhangy@mail.kiz.ac.cn (Y. Zhang).
0014-5793/$30.00  2005 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2005.07.010ical defense system composed of pharmacological and antimi-
crobial peptides [4]. A considerable variety of antimicrobial
peptides have been characterized from amphibians. Based on
their sequence/three-dimensional structure characteristics, the
microbicidal peptides from amphibian skin can be grouped
into three broad families [5–7]. The ﬁrst one contains linear
amphipathic helix forming peptides such as magainins from
African clawed frog Xenopus laevis, bombinin-like peptides
(BLPs) from Bombina orientalis and B. variegata. The second
family has four diﬀerent groups of related peptides isolated
from various Ranidae species, which all contain two cysteine
residues at the C-terminal part that form a disulﬁde bond.
The third one includes temporins from Rana temporaria, which
are only 10–13 amino acid residues long.
These antimicrobial peptides have been shown to have a
broad antimicrobial spectrum, able to kill most strains of bac-
teria as well as some fungi, and in addition, many types of tu-
mor cells. The detailed molecular mechanism of their
antimicrobial activity and selectivity has not been clearly eluci-
dated. However, speciﬁcity for pathogenic cells is thought to
be due to the composition of the cell membranes. An increased
proportion of anionic phospholipids making the pathogen
more susceptible and the presence of cholesterol making the
membranes more resistant to the peptides are reviewed in [8].
The Chinese red belly frog (B. maxima) is an endemic
amphibian distributed in the mountainous area of south-
western China. It has long been known by the indigenous
people that the frog lives in very harsh environments like
pools with microorganism-rich mud. Our recent studies
showed that the skin secretions of B. maxima contain a large
number of new antimicrobial peptides. Maximins and maxi-
min Hs, which are equivalent to BLPs and bombinin Hs
identiﬁed in two other Bombina species, B. orientalis and
B. variegata, respectively [9,10]. Particularly, maximin H5
represents the ﬁrst example of anionic antimicrobial peptides
from amphibians, providing evidences that together with cat-
ionic antimicrobial peptides, anionic antimicrobial peptides
also exist naturally as part of the innate defense system
[10]. Maximin S4, member of a novel group of antimicrobial
peptides of 14–18 amino acid residues long, was found to
have antimycoplasma activity but not anti-bacterial or
anti-fungal activities [11].
Here, we reported identiﬁcation, cDNA cloning, synthesis
and antimicrobial activity of a novel maximin (maximin 9)
peptide, which is characterized by a free cysteine in the middle
part of the molecule. With speciﬁcity targeting on myco-
plasma, maximin 9 might represent the ﬁrst example of free
thiol containing antimicrobial peptides from vertebrates.blished by Elsevier B.V. All rights reserved.
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2.1. Construction and sequencing of a cDNA library
Adult specimens of Chinese red belly frogB. maximawere collected in
ChuxiongCounty,YunnanProvince, SouthWest of PRChina.mRNAs
were prepared from the total RNA extracted from the skin of a single
individual by oligo(dT) cellulose chromatography with a mRNA puriﬁ-
cation kit (Promega). A directional cDNA library was constructed with
plasmid cloning kit (SuperScript Plasmid System, GIBCO/BRL) with
some modiﬁcations as described previously [9]. Brieﬂy, linkers contain-
ing a NotI restriction site and a SalI site were added to size-selected
cDNAs. These cDNAs were cloned into the pSPORT1 vector (GIB-
CO/BRL) by insertion at theNotI andSalI site of pSPORT1 vector arms
and used to transform Escherichia coliHB101 competent cells, produc-
ing a library of about 2.8 · 104 independent colonies.
In attempt to analyze the expression proﬁle of the frog skin, a strat-
egy of random sequencing of the cloned cDNAs was used [12]. Brieﬂy,
the library was titered and bacteria were plated out in LB plates con-
taining 100 lg/ml ampicillin. Single colonies were picked out and ana-
lyzed by PCR to conﬁrm the presence of an insert sequence and its size
(>500 bp), under the following conditions: 2 min at 94 C, followed by
30 cycles of 10 s at 92 C, 30 s at 50 C, 40 s at 72 Cwith a Peltier Ther-
mal Cycler (model PTC-200, M.J. Research, USA). A vector T7 primer
(5 0-GTAATACGACTCACTATAGGGCGA-3 0, in the sense direc-
tion) and a vector SP6 promoter primer (5
0-CATACGATTTAGGT-
GACACTATAG-3 0, in the antisense direction) located in 5 0 and 3 0 of
the cloned insert, respectively, were used in PCR analysis. All the oligo-
nucleotide primers for PCR were prepared with a DNA synthesizer
(Model 381A, Applied Biosystems). For obtained antimicrobial peptide
full-length cDNAs, both strands of the clones were sequenced on an
Applied Biosystems DNA sequencer, model ABI PRISM 377. Com-
puter analysis of protein sequences and nucleotide acid sequences were
performed with the Clustal V sequence software package.
2.2. Peptide synthesis
Amidatedmaximin 9, Cys16-Gly16 mutant of maximin 9 and homodi-
mer of maximin 9 were synthesized by solid phase synthesis on an
Applied Biosystems model 433A peptide synthesizer according to the
manufacturers standardprotocols.After cleavage and side-chaindepro-
tection, the crude synthetic peptide was puriﬁed on a Vydac 218TP510
C18 reverse phase-HPLC column (25 · 1 cm) eluted at a ﬂow rate of 2
ml/min by a linear gradient of acetonitrile in 0.1% triﬂuoroacetic acid
in water. Identity of the peptide was conﬁrmed by automated Edman
degradation with a protein sequencer and mass spectrometry analysis.
Fast atombombardmentmass spectrometrywas carriedout on anAuto-
spec-3000 spectrometer, equipped with a high ﬁeld magnet [9]. The syn-
thetic peptides were then used for evaluating biological activities. The
peptides were quantiﬁed by UV absorbance at 215 and 225 nm using
the formula: concentration (mg/ml) = (A215–A225) · 0.144.
2.3. Antimicrobial assays
Microbial strains used in antimicrobial assays, Gram-positive bacte-
rial strains Staphylococcus aureus (ATCC2592), Gram-negative bacte-
rial strains E. coli (ATCC25922), Bacillus pyocyaneus (CMCCB10104),
fungal strains Candida albicans (ATCC2002), were obtained from
Kunming Medical College. Antimicrobial activity was assayed as de-
scribed previously [9]. Minimal inhibitory concentration (MIC) was
determined in liquid LB medium at pH 7.0 by incubating the bacteria
in LB broth with variable amounts of the sample tested. The MIC at
which no growth occurred, as measured at absorbance of 600 nm,
was recorded. The eight strains of Mollicutes, including two clinic
strains ofMycoplasma hominis and six clinic strains of Ureaplasma ure-
alyticum, were obtained from The First Peoples Hospital of Yunnan
Province. The mollicutes were cultured under anaerobic conditions
at 37 C for 48 h in appropriate liquid media (starting pH 6.0) as de-
scribed [13,14]. Inhibitory eﬀects were determined by culturing the cells
in 96-well microtitration plates in the presence of 2-fold serial dilutions
of the peptides and following the color change of phenol red resulting
from acidiﬁcation of the culture medium during growth. The starting
cell concentration was 105 colony-forming units (CFU/ml). To analyze
the eﬀect of a reducing agent on the activity of maximin 9, 5 mM (ﬁnal
concentration) dithiothreitol (DTT, Sigma) was added to the growth
medium. Organisms were considered to be resistant when their growth
was not prevented by ﬁxed peptide concentrations of 30 lM.2.4. Hemolytic assays
Hemolytic assay was tested with human erythrocytes in liquid med-
ium as reported [9]. Serial dilutions of the peptides with or without
DTT (2 mM, ﬁnal concentration) were used, and after incubation at
37 C for 30 min, the cells were centrifuged and the absorbance of
the supernatant was measured at 595 nm. Maximum hemolysis was
determined by adding 1% Triton X-100 to the tested cells.3. Results and discussion
3.1. cDNA cloning
Seven hundred and ninety-three clones, which contain an
insert larger than 500 bp from a cDNA library constructed
from B. maxima individual A skin, were randomly picked
out and sequenced. Total 92 antimicrobial peptide clones, with
an insert around 650-bp, were identiﬁed and isolated by ran-
dom sequencing. Meanwhile, by PCR-based high stringency
screening method [15], thirty B. maxima antimicrobial peptide
clones were screened out and sequenced from another con-
structed individual B skin cDNA library. Both strands of these
clones were sequenced. In addition to previously identiﬁed
clones that encode previously puriﬁed antimicrobial peptides
maximins 1–5, and maximins H1–H5 [9,10], approximate 30
novel clones were found to encode new antimicrobial peptide
precursor proteins. The encoded precursors comprise either a
novel maximin with a novel maximin H peptide, or diﬀerent
combinations of these two kinds of peptides. Surprisingly,
both clone 252 and clone 91 contain an insert that encodes a
precursor protein comprising a novel antimicrobial peptide
(designated as maximin 9) and previously reported maximin
H3. The open reading frame and 3 0-untranslated region of
clone 252 and clone 91 are identical, but clone 91 have fewer
nucleotides at 5 0-untranslated region compared with clone
252. The complete nucleotide sequence and the deduced amino
acid sequence of clone 252 are shown in Fig. 1. The overall
structure of clone 252 cDNA is similar to that of the cDNAs
encoding other maximins and maximin Hs. Like previously re-
ported clone 96 cDNA that encodes maximin 4 plus maximin
H3, clone 252 cDNA was found to contain a coding region of
435 nucleotides. The encoded amino acid sequence corre-
sponds to a polypeptide of 144 amino acid residues, which is
composed of a signal peptide, an acidic peptide, a novel homo-
logue of maximin peptides, spacer octapeptide, another acidic
peptide plus ﬁnally a C-terminal maximin H3 peptide. Com-
paring with maximins 1–5, the deduced amino acid sequence
of the acidic peptide followed signal peptide is: RSXXX-
XXQSLSQRDVLEEESLREIR, the putative C-terminal of
maximin 9 is followed by GKR, in which the glycine provides
the amide for the C-terminal tyrosineamide of the peptide and
the dibasic site (Lys-Arg) forms the cleavage site for the releas-
ing of the mature peptide. Thus, amino acid sequence of the
deduced mature maximin 9 is GIGRKFLGGVKTTFRC-
GVKDFASKHLY-NH2. As compared in Fig. 2, this novel
peptide is a homologue of maximin peptides (sequence identi-
ties around 26–48% with maximins 1–11). The conserved resi-
dues are found at positions 2–3, 11, 19 and 22 compared with
other reported maximins 1–11 originated from the same
sources. Surprisingly, diﬀerent from all maximins so far identi-
ﬁed, maximin 9 is characterized by a single unique cysteine res-
idue at positions 16. In addition, several signiﬁcant
replacements are observed among maximin 9 and maximins
1–11. Maximin 9 diﬀers by amino acid substitutions with
Fig. 1. Complete nucleotide sequence and deduced amino acid sequence of the cDNA encoding maximin 9 plus maximin H3 (clone 252), and
comparison with those of the cDNA encoding maximin 4 plus maximin H3 (clone 96) [9]. The nucleotides of protein coding region are shown by
uppercase letters and those of noncoding region by lowercase letters. The deduced amino acid sequence is shown below. Gaps (–) have been
introduced to optimize the sequence homology. Maximin H3 peptide sequences are boldfaced and italicized. The sequences of maximin 9 and
maximin 4 are boldfaced. Dots (  ) indicate the same nucleotide residue and amino acid residue in both cDNAs.
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Tyr/Phe at position 25 in maximins 1–11 is replaced by His25 in
maximin 9. The well conserved hydrophobic residue at posi-
tion 4 among maximins 1–11 is replaced by a basic Arg4 in
maximin 9 (Fig. 2). No other cysteine-containing antimicrobial
peptide precursor was found from the two constructed skin
cDNA libraries of B. maxima in this study.
It has been reported that in animals, including amphibians,
antimicrobial peptides exhibit high levels of variation caused
by selection pressure responding to a diversity of quicklyevolving pathogens [16,17]. As compared in Fig. 1, sequence
identity between cDNAs of clones 252 and 96 is 89.4% in the
coding regions. Remarkably, the main diﬀerence was observed
in the maximin peptide coding sequences, in which 30 nucleo-
tide mutations resulted in 19 amino acid residue substitutions.
All nucleotide mutations are necessary nonsynonymous muta-
tions for encoding novel maximin 9 peptide. Among all the
antimicrobial peptides obtained, we found that the mean num-
ber of nucleotide substitution per nonsynonymous site in both
the maximin and maximin H domains signiﬁcantly exceed the
Fig. 2. Primary structures of maximin peptides. Identical residues
among maximin peptides are boldfaced. Signiﬁcant amino acid
substitutions are shaded. The sequences of maximins 1–11 are from
[9,10,18].
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whereas the same pattern was not observed in other structural
regions, such as the signal and propiece peptide regions, sug-
gesting that these antimicrobial peptides have been experienc-
ing rapid diversiﬁcation driven by Darwinian selection [18].
3.2. Antimicrobial activity
According to the deduced primary structure of maximin 9
from its cDNA sequences, the peptide was chemically synthe-
sized in a C-terminal amidated form by peptide synthesizer and
used in antimicrobial assays. To better evaluate the contribu-
tion of Cys16 in the antimicrobial activity of the peptide, a
maximin 9 Cys16-Gly16 mutant was synthesized based on the
well conserved Gly16 in maximins 1–11. Homodimer of maxi-
min 9 was also synthesized in a C-terminal amidated form and
its antimicrobial activity was tested.
The antibacterial activity of maximin 9, its Cys16-Gly16 mu-
tant and homodimer were tested on diﬀerent bacterial and fun-
gal strains. Unlike previously reported maximin 3 that
possesses potent antimicrobial activity and broad antimicro-
bial spectrum on tested strains with MICs within 1–20 lM
[9], the tested bacterial and fungal strains were resistant to
maximin 9, its homodimer and the Cys16-Gly16 mutant (with
MICs > 100 lM) (Table 1). In the presence of DTT, S. aureus
and E. coli were found to be more sensitive to maximin 9 with
observed MICs changed to 100 and 75 lM, respectively. On
the other hand, the decreases of MIC values of the Cys16-
Gly16 mutant on S. aureus and E. coli were also observed.
DTT (a reducing agent) alone (2 mM, ﬁnal concentration)
inﬂuenced the growth of the tested bacteria S. aureus and
E. coli, showing a 20–30% inhibition, while it did not aﬀectTable 1
Antimicrobial activity of maximin 9
Microorganisms MIC (lM)
Maximin 9 Maximin 9
plus DTT
Staphylococcus aureus ATCC2592 R 100
Escherichia coli ATCC25922 150 75
Bacillus pyocyaneus CMCCB10104 R R
Candida albicans ATCC2002 R R
The data represent mean values of three independent experiments performe
peptide concentrations up to 100 lM). MIC > 150 lM: a slowing down of the
the MIC could not be obtained when the peptide dosages used up to 150 lMthe growth of B. pyocyaneus and C. albicans in the assay sys-
tems. In the presence of DTT, increase of the sensitivities of
bacteria S. aureus and E. coli to both maximin 9 and its
Cys16-Gly16 mutant might be either caused by the inﬂuence
of DTT on the growth of the strains or by the enhancing eﬀect
of DTT on the sensitivities of the strains to the peptides. Sim-
ilar to maximins 1–5, maximin 9, the homodimer and its Cys16-
Gly16 mutant did not induce hemolysis of human red cells in
the presence or absence of DTT under the tested concentration
up to 100 lM.
Mycoplasma belong to the class of Mollicutes. These ‘‘soft
skin’’ bacteria emerged from the Gram-positive branch of
the eubacterial phylogenetic tree by genome size reduction to
such an extent that several mycoplasma species are the smallest
and the simplest self-replicating organisms [19,20]. Since these
bacteria have no cell wall, unlike typical bacteria, their plasma
membrane contains cholesterol to stabilize the membrane. The
sensitivities of eight clinical strains of Mollicutes (two of M.
hominis and six of U. urealyticum) to maximin 9, the homodi-
mer and its Cys16-Gly16 mutant were tested (see Table 2).
Interestingly, in our assay conditions, four out of eight clinical
strains were found to be sensitive to maximin 9 with varied
sensitivities. Furthermore, the activity was found to be depen-
dent on a reducing environment. Since two strains of M. hom-
inis, which were resistant to maximin 9 in the absence of DTT,
were found to become sensitive to the peptide after addition of
DTT. It should be noted that the oxidation of free thiol by air
is limited in our assay conditions as the test samples and the
culture media were covered with mineral oil to maintain anaer-
obic conditions. In addition, in a parallel experiment, the pres-
ence of DTT did not inﬂuence the growth of tested
mycoplasma strains. In the cases of maximin 9 homodimer
and its Cys16-Gly16 mutant, the majority of the strains tested
were resistant to them. This is in accordance with the results
of magainins, a representative of these linear amphipathic anti-
microbial peptides from amphibians. When tested the antibi-
otic activity of several amphipathic peptides from diﬀerent
origins on mycoplasma strains, it was proven that the assayed
mycoplasma strains, like M. gallisepticum, M. genitalium are
fully resistant to the magainins, even when used at concentra-
tions up to 100 lM [14]. Diﬀerent from the case of maximin 9,
the presence of DTT did not increase the sensitivities of the
mycoplasma strains to the Cys16-Gly16 mutant.
The experimental results indicate that the presence of a reac-
tive Cys residue in maximin 9 do have some eﬀects on its
antimycoplasma properties. This is probably due to the inter-
action of free Cys residues with thiol groups on the outside of










d in duplicates. R, resistance (growth of the organisms unaﬀected by
growth of the organisms was observed at concentrations >100 lM, but
.
Table 2
Antimycoplasma activity of maximin 9 on assayed clinical mycoplasma strains
Microorganisms Sensitivities to maximin 9, its derivatives and antibiotics








ERY LML OFL ROX AZI
M. hominis
Strain 1 R ++ R R R R R R R R
Strain 2 R ++ R R R + R + ++ ++
U. urealyticum
Strain 1 ++ + R R R R + + ++ +
Strain 2 R R R + + + + + + ++
Strain 3 ++ ++ R R R R + + + +
Strain 4 ++ ++ R + + + R R ++ ++
Strain 5 + R R R R + R + ++ ++
Strain 6 R ++ + R R R + ++ + +
The data represent three parallel experiments. R, resistance (growth of the organisms unaﬀected in the presence of the peptides or antibiotics); ++,
growth of the organisms was totally inhibited; +, a slowing down of the growth of the organisms was observed. ERY, erythromycin; LML,
lomeﬂoxacin; OFL, oﬂoxacin; ROX, roxithromycin; AZI, azithromycin. The peptide and the antibiotic concentrations used in the experiments are
ﬁxed at 30 lM and 10 lg/ml, respectively.
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duced by certain Lactococcus lactis strains [21,22]. Lactococcin
B contains naturally one Cys residue and two mutants of nisin
Z (S5C and M17C) contain engineered one Cys residue in each
molecule. It was observed that they exhibit antimicrobial activ-
ity when the Cys residue is in the reduced state. Alternatively,
the existence of a reactive Cys residue in maximin 9 might also
facilitate its attack on Mollicutes strains by using cholesterol as
a target, as those observed for a widespread group of mem-
brane-damaging thiol-activated toxins, active against mamma-
lian cells. These toxins all contain a single Cys residue, which
facilitates their binding to cholesterol-containing membrane
[23].
Homodimeric and heterodimeric antimicrobial peptides
linked with one disulﬁde bond were reported from diﬀerent
species. Dicynthaurin puriﬁed from hemocytes of Halocynthia
aurantium and 11-kDa polypeptide from Guinea pig neutro-
phils are homodimers [24,25]. Halocidin and distinctin are het-
erodimers (composed of two similar monomers) naturally
existed in hemocytes of H. aurantium and skin secretions of
tree-frog Phyllomedusa distincta, respectively [26,27]. Haloci-
din is composed of two peptides of 18 amino acid residues
and 15 amino acid residues long. Experimental results indi-
cated that besides puriﬁed heterodimer, the 18-amino acid res-
idues monomer and its homodimer also show potent
antimicrobial activities on tested strains of S. aureus and Pseu-
domonas aeruginosa, and the activities are even stronger than
those of puriﬁed heterodimeric halocidin [26], suggesting the
natural existence of its monomer and homodimer. Diﬀerently,
in the case of maximin 9, both monomer and homodimer
showed very poor antimicrobial activities on tested bacterial
and fungal strains. The signiﬁcant diﬀerence between maximin
9 and its homodimer observed at present study is that maximin
9, but not its homodimer, possesses antimycoplasma activity
that is enhanced in a reducing environment. Thus, maximin
9 might represent a novel class of antimycoplasma peptide,
which is free thiol dependent.
Amphibians have naked skin and show a marked preference
for damp habitats that teem with potentially diverse patho-
genic bacteria and fungi. Diverse antimicrobial peptides in B.
maxima skin are necessary for its antipathogen potential and
wider antipathogen spectrum. Unfortunately, from skin secre-
tions of 20 individuals of B. maxima, neither maximin 9 mono-mer nor maximin 9 homodimer was identiﬁed by MALDI-
TOF mass analysis from partially puriﬁed antimicrobial frac-
tions in our previous experiments [11]. Evidences revealed that
bathing B. orientalis with bacteria induced a signiﬁcant
increase in the biosynthesis of antibacterial peptides, and the
expression of the antibacterial peptides in B. orientalis was reg-
ulated by NF-jB and NF-IL6 [28,29]. Moreover, the synthesis
of antimicrobial peptides in skin glands of R. esculenta is also
demonstrated to be induced by the presence of microorganisms
but not under sterile conditions, suggesting that this phenom-
enon might be common in amphibians [30]. We have recently
demonstrated that the putative recognition sites of NF-jB
and NF-IL6 in B. maxima skin and liver genomic antimicro-
bial peptide DNAs are identical to those of B. orientalis [18].
Thus, the expression and regulation of antimicrobial peptides
in B. maxima should be similar to that of B. orientalis.
Whether the expression of maximin 9 will be enhanced by
mycoplasma bathing need to be further investigated.
The existence of maximin 9 coding cDNAs in two individual
B. maxima skin cDNA libraries should have important contri-
bution in the innate immunity defense system of the frog.
Coevolution of host-pathogen, as have been observed in major
histocompatibility complex class I [31] and merozoite surface
antigen-1 [32], may provide evolution forces for the frog to
achieve the relevant antimicrobial factors. The diversity of
antimicrobial peptide cDNA structures encountered in B.
maxima skin cDNA libraries and the antimicrobial speciﬁcity
diﬀerences of the peptides may reﬂect well the species adapta-
tion to the unique microbial environments.
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